Physician profile
Jon Bruce Obray
NPI 1205814803
$23,854.60
in general payments reported to CMS, 2019-2025
21 companies · $1,483 in 2025
The $1,483 reported for 2025 was more than what 76% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $655 · 2020: $643 · 2021: $725 · 2022: $18K · 2023: $352 · 2024: $2,013 · 2025: $1,483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,151 · Travel and Lodging: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,150.78 |
| Travel and Lodging | $697.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tenon Medical, INC. | $17,234.33 | 2022 | |
| Boston Scientific Corporation | $4,533.22 | 2019-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Relievant Medsystems, INC. | $458.02 | 2019-2023 | Intracept |
| Abbott Laboratories | $355.31 | 2019-2021 | |
| Abbvie INC. | $198.20 | 2022-2025 | |
| Nevro Corp. | $156.60 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $127.65 | 2024-2025 | |
| Stryker Corporation | $108.78 | 2019-2025 | Optablate |
| Medtronic, INC. | $106.02 | 2022-2025 | Vanta Adaptivestim, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Grt US Holding, INC. | $94.99 | 2022 | |
| Allergan, INC. | $79.72 | 2019-2022 | |
| Lundbeck LLC | $79.24 | 2023-2025 | Vyepti |
| Vertiflex, INC. | $74.64 | 2019 | |
| Spr Therapeutics, INC | $60.78 | 2024-2025 | Sprint Pns System |
| Henry Schein, INC. | $43.46 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $31.65 | 2022 | |
| Depuy Synthes Sales INC. | $30.51 | 2022 | |
| Nalu Medical, INC. | $28.97 | 2024 | Nalu Neurostimulation System |
| Stimwave Technologies Incorporated | $21.41 | 2020 | |
| Medtronic USA, INC. | $19.74 | 2019 | |
| Pfizer INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$36,050.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Obray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.